Post-marketing study of ropinirole prolonged release tablets in Parkinson’s disease: Evaluation outcomes associated with long term use of Ropinirole-PR using the clinical practice research datalink (CPRD) (111981)First published 23/02/2016 Last updated 23/05/2024 EU PAS number: EUPAS12518StudyFinalised